Latest Posts
About This Stock
More About This Stock
Read
Read
Read
A Peek Into Latest 13-F Filing: Top Hedge Fund Stocks
Article By:
Sweta Killa
Friday, May 18, 2018 9:08 PM EST
Investors are mulling over the top bets of big investors like Bill Ackman, George Soros, Carl Icahn, David Tepper, Larry Robbins, Leon Cooperman, Daniel Loeb, David Einhorn and Stanley Druckenmiller, following the first-quarter release of 13F Forms.
In this article: EA, AAPL, ADBE, AMZN, MSFT, NFLX, FB, GOOGL, TWX, UNH, ANTM, CVS, ESRX, GRBK, TUSK, GHDX, ZGNX, RTRX, PCRX, PTCT, CORI, SBBP
XBI Breaks Through On A Strong Week For Biotech
Article By:
Rod Raynovich
Friday, September 29, 2017 7:25 PM EST
The XBI is up 3.17% this week, 46% YTD, compared to only 1.1% WTD for the IBB. The breakthrough gains for the XBI can be attributed to strong performance of top ten holdings that are primarily mid-caps and M&A prospects.
In this article: BMY, ALNY, BMRN, IBB, AMGN, CELG, CLVS, XBI, JUNO, PBYI, SRPT, BLUE, PTCT, ABBV, FMI
PTC Therapeutics Should Be Bought On Today's Sell-Off, Says Citi
Article By:
The Fly
Friday, September 29, 2017 8:43 AM EST
Citi analyst Joel Beatty, while conceding the FDA is unlikely to approve Translarna after yesterday's 10-1 panel vote in favor of needing more data, recommends buying shares of PTC Therapeutics today on the sell-off.